Qingdao, China

Dayong Shi

This inventor holds 1 USPTO granted patent. Top assignee: Lead High Technology (Qingdao) Co., Ltd. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dayong Shi. Retrieved from https://idiyas.com/inventor/dayong-shi-3mwwy60f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dayong Shi: Innovator in Pharmaceutical Chemistry

Introduction

Dayong Shi is a prominent inventor based in Qingdao, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential applications in treating viral infections.

Latest Patents

One of Dayong Shi's notable patents is for a bromophenol-pyrazoline compound and its synthesis method and use. This invention relates to a compound that exhibits efficient inhibitory activity against the main protease M, which is crucial in the replication of coronaviruses. The compound shows promise in treating coronavirus pneumonia, indicating its potential for application in drug development aimed at combating this serious health issue.

Career Highlights

Dayong Shi is currently associated with Lead High Technology (Qingdao) Co., Ltd. His work at this company focuses on innovative solutions in the pharmaceutical sector, contributing to advancements in drug synthesis and development.

Collaborations

Throughout his career, Dayong Shi has collaborated with notable colleagues, including Xiangqian Li and Xin Wang. These partnerships have fostered a collaborative environment that enhances research and development efforts in their field.

Conclusion

Dayong Shi's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key inventor in the fight against viral infections. His work continues to pave the way for advancements in drug development and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…